Second Oklahoma Prostate and Urologic Cancers Symposium

The Second Oklahoma Prostate and Urologic Cancers Symposium addresses newer advances in areas of interest for urologic cancers. The single-day program will consist of lectures and case discussions highlighting the multidisciplinary coordination of cancer care and the application of progressive technology to cancer care. Evidence-based medicine highlighting relevant clinical trial data will be provided as well as current controversies involving such care. Experts on the subject will present lectures and be available for questions and case discussions. 

1. Describe guidelines for bladder cancer detection and management.
2. Describe therapies and treatments for kidney cancer.
3. Identify the new genetic markers and their use in the detection and management of prostate cancer.
4. Describe the risks and benefits of the various treatment modalities for localized prostate cancer.
5. Identify strategies for improved quality of care in survivorship for prostate cancer patients.

Early Bird Registration Fee (Postmarked by September 9, 2016)
Physicians:  $100
Physician Assistant, Nurse Practitioner, Other Health Care Professional:  $25
Residents/Fellows:  $0 

Regular Registration Fee (Postmarked after September 9, 2015)
Physicians:  $125
Physician Assistant, Nurse Practitioner, Other Health Care Professional:  $25
Residents/Fellows:  $0 

Cancellation Fee: $75 

No refunds issued after September 16, 2016

The University of Oklahoma College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Oklahoma College of Medicine designates this live activity for a maximum of 5.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Conflict Resolution Statement:
The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and resolved all identified conflicts of interest, if applicable.

Nondiscrimination Statement:
The University of Oklahoma, in compliance with all applicable federal and state laws and regulations does not discriminate on the basis of race, color, national origin, sex, sexual orientation, genetic information, gender identity, gender expression, age, religion, disability, political beliefs, or status as a veteran in any of its policies, practices, or procedures. This includes, but is not limited to: admissions, employment, financial aid, and educational services. 

Accommodation Statement:
Accommodations on the basis of disability are available by contacting Stevie Warner at (405) 271-2537 or [email protected] as soon as possible.

Acknowledgement of Commercial and In-Kind Support:
Commercial support is financial, or in-kind, contributions given by a commercial interest, which is used to pay all or part of the costs of a CME activity.  A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Appropriate acknowledgement of all commercial and in-kind support will be given at the time of the educational activity.

Disclaimer Statement:
Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.
Every reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.

Policy on Faculty and Presenters Disclosure
It is the policy of the University of Oklahoma College of Medicine that the faculty and presenters disclose real or apparent conflicts of interest relating to the topics of this educational activity, and also disclose discussions of unlabeled/unapproved uses of drugs or devices during their presentation(s).  

Samis Education Center 

1200 Children's Avenue

Oklahoma City, OK 73105

Complimentary Parking in the Events Parking Lot.

Directions from the South
  › From I-35, continue on I-235 North
  › Take Exit 1D for Lincoln Blvd.
  › Turn right on NE 10th St. from Lincoln Blvd.
  › Go left on Phillips Ave. for The Children's Hospital

Directions from the North › From I-235, take Exit 1G at NE 10th St.
  › Turn left onto NE 10th St.
  › Go left on Phillips Ave. for The Children's Hospital

Google Maps Link:  https://www.google.com/maps/

Planning Committee Members: 

Michael Cookson, MD-Course Director
Kelly Stratton, MD-Course Director
Claire Turmelle, BA
Sharon Kern
Abby Moeller, PA-C
Stevie Warner-Course Contact

Ashley B Bowen, MD, MBA
University of Oklahoma College of Medicine
Oklahoma City, OK

Michael S Cookson, MD, MMHC, FACS
University of Oklahoma College of Medicine
Oklahoma City, OK

Brian W Cross, MD
University of Oklahoma College of Medicine
Oklahoma City, OK

Jarrad Garner
Plevex and V. Mueller
Oklahoma City, OK

Sofia Ghani, MD
OUHSC
Oklahoma City, OK

Michael R Harrison, MD
Duke Cancer Institute
Durham, NC

Jonathan E Heinlen, MD
University of Oklahoma College of Medicine
Oklahoma City, OK

Mark C Lindgren, MD
University of Oklahoma College of Medicine
Oklahoma City, OK

Chance Matthiesen, MD
University of Oklahoma HSC
Oklahoma City, OK

Sanjay G Patel, MD
University of Oklahoma College of Medicine
Oklahoma City, OK

Mohammad O Ramadan, MD
OU Physicians Building
Oklahoma City, OK

Kelly L Stratton, MD
University of Oklahoma College of Medicine
Oklahoma City, OK

J Brantley Thrasher, MD
University of Kansas Medical Center
Kansas City, KS

Eric S Wisenbaugh, MD
University of Oklahoma, College of Medicine
Oklahoma City, OK

Saturday, September 24, 2016

Acknowledgement of Commercial and In-Kind Support

Commercial support is financial, or in-kind, contributions given by a commercial interest, which is used to pay all or part of the costs of a CME activity.  A commercial interest is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.

Appropriate acknowledgement of all commercial and in-kind support will be given at the time of the educational activity.